“How We'd Prepare For A -50% Stock Market CRASH”
$IBBBullish
AI summary · IBB is another interesting one: biotech sits at a singularity point for AI's positive impact on research, and with petabytes of data now available, the speaker sees the early innings of a potentially massive singularity event for healthcare in America and globally, starting with biotech names.
There's also IBB, which is the EyesShares biotechnology ETF that exists out there. I think biotech is at its like singularity when it comes to how artificial intelligence can positively impact the research done.